SIMPLEX TRADING, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 92 filers reported holding ENZO BIOCHEM INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2023$21
-90.3%
11,705
-86.8%
0.00%
Q1 2023$216
+111.8%
88,897
+23.7%
0.00%
Q4 2022$102
-99.8%
71,871
+159.2%
0.00%
Q3 2022$61,000
+134.6%
27,731
+117.0%
0.00%
Q2 2022$26,000
-29.7%
12,777
-1.9%
0.00%
Q1 2022$37,000
-48.6%
13,027
-42.1%
0.00%
Q4 2021$72,000
-60.4%
22,481
-61.2%
0.00%
Q3 2021$182,000
-0.5%
57,9600.0%0.00%
Q2 2021$183,000
-66.4%
57,960
-63.5%
0.00%
-100.0%
Q1 2021$545,000
+77.5%
158,642
+30.0%
0.00%
Q4 2020$307,000
+707.9%
122,039
+567.9%
0.00%
Q3 2020$38,000
-11.6%
18,273
-6.7%
0.00%
Q2 2020$43,000
+290.9%
19,582
+329.9%
0.00%
Q1 2020$11,000
+450.0%
4,555
+470.8%
0.00%
Q4 2019$2,000
-50.0%
798
-39.1%
0.00%
Q3 2019$4,0000.0%1,311
-4.6%
0.00%
Q2 2019$4,0001,374
+2444.4%
0.00%
Q4 2018$0
-100.0%
54
-94.9%
0.00%
Q3 2018$4,000
-60.0%
1,064
-47.0%
0.00%
Q2 2018$10,000
-28.6%
2,009
-22.2%
0.00%
-100.0%
Q1 2018$14,000
+55.6%
2,582
+122.4%
0.00%
Q4 2017$9,000
-50.0%
1,161
-33.2%
0.00%
-100.0%
Q3 2017$18,000
+500.0%
1,738
+53.5%
0.00%
Q3 2015$3,000
-66.7%
1,132
-63.5%
0.00%
-100.0%
Q2 2015$9,000
-92.7%
3,100
-92.6%
0.00%
-92.9%
Q1 2015$123,00041,9010.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2018
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,886,771$10,219,00013.54%
HARBERT FUND ADVISORS, INC. 5,175,913$18,323,0006.51%
Evermore Global Advisors, LLC 1,730,607$6,126,0005.39%
VIEX Capital Advisors, LLC 1,510,401$5,347,0003.24%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$90,0000.05%
RBF Capital, LLC 250,359$886,0000.05%
CORRADO ADVISORS, LLC 19,366$69,0000.04%
Cutter & CO Brokerage, Inc. 27,827$99,0000.02%
Ergoteles LLC 177,048$627,0000.02%
FULLER & THALER ASSET MANAGEMENT, INC. 941,760$3,334,0000.02%
View complete list of ENZO BIOCHEM INC shareholders